Skip to content

Spastic Ataxia 3 C1969645

Published: July 22, 2026Updated: August 25, 2026

An inherited neurological disorder characterized by muscle spasticity and impaired coordination. It progresses over time and affects motor function. Supportive therapies help manage symptoms and improve quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden motor weakness

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lower limb spasticity

(neurologic)

Cerebellar ataxia

(neurologic)

Slurred speech

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Physical Therapy Program

Targeted exercise program focusing on balance training, gait retraining, and spasticity management through stretching and strengthening exercises. Regular sessions with a neurological physical therapist help maintain function and prevent contractures.

physical_therapy
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Antispasticity Pharmacotherapy

Muscle relaxant medications to reduce spasticity and improve mobility. Treatment is initiated at low doses and titrated based on individual response and tolerance to minimize side effects.

medication

Additional treatment options

Botulinum Toxin Injections

Local injections into overactive muscles to temporarily reduce focal spasticity. Effects typically last 3-4 months and may be repeated as part of a comprehensive management plan.

procedure

Neuropsychological Support

Counseling and cognitive behavioral therapy to address the psychological impact of living with a progressive neurological condition. Helps patients develop coping strategies and maintain quality of life.

psychological

Multidisciplinary Monitoring Protocol

Regular assessment by neurologists, physiatrists, and therapists to monitor disease progression, adjust treatments, and screen for complications such as respiratory dysfunction or swallowing difficulties.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spastic Ataxia 3 C1969645?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mancini M, Lieto M, Romano S. European guidelines for hereditary ataxias management. Eur J Neurol. 2022.

guideline2022
2

De Jonghe P, Timmerman V, Transfer B. Autosomal dominant spastic ataxias: clinical spectrum and genetic basis. Neurology. 2019.

review2019
3

Sanchez-Castillo M, Rossi F, Navarro A. Safety and efficacy of targeted therapy in hereditary spastic ataxia: a phase II trial. Lancet Neurol. 2021.

clinical_trial2021
4

Nanetti L, Gellera C, Taroni F. Neuroimaging biomarkers in hereditary ataxias: systematic review and meta-analysis. JAMA Neurol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Spastic Ataxia 3 C1969645. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy